Literature DB >> 18761663

Alteration of the immunological synapse in lung cancer: a microenvironmental approach.

S Derniame1, J-M Vignaud, G C Faure, M C Béné.   

Abstract

This study was designed to investigate the immunological properties of stroma reaction T cells and tumoral cells by comparison with non-tumoral lung tissue and local lymph nodes in order to explore interactions between tumour cells and the immune system. Immunodetection of major histocompatibility complex (MHC) molecules, CD3/T cell receptor (TCR) complex and T cell subsets markers was carried out in situ on frozen sections, and the semi-quantitative expression of CD3, CD4 and CD8 was examined in flow cytometry on lymphocytes of nodal, tumoral and healthy lung tissue from 62 patients with non-small cell lung cancer. This study showed alterations on lymphocytes and tumour cells in lung cancer, consistent with an impairment of T cell activation. CD3, TCR alpha beta and accessory molecules expression is down-modulated on peri- or intra-tumoral lymphocytes. MHC class I and class II molecules are down-modulated significantly on tumour cells. Other differences were noted, such as the reversed CD4/CD8 ratio of tumour infiltrating cells, compared to healthy lung tissues, consistent with the development of cytotoxic anti-tumoral responses. This study reports on the presence of a strong in vivo immunomodulating effect of tumour cells in human non-small cell lung cancer, likely to impair proper formation of the immunological synapse.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18761663      PMCID: PMC2561083          DOI: 10.1111/j.1365-2249.2008.03727.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

Review 1.  Information transfer at the immunological synapse.

Authors:  J Delon; R N Germain
Journal:  Curr Biol       Date:  2000 Dec 14-28       Impact factor: 10.834

Review 2.  HLA class I antigen abnormalities and immune escape by malignant cells.

Authors:  Barbara Seliger; Teresa Cabrera; Federico Garrido; Soldano Ferrone
Journal:  Semin Cancer Biol       Date:  2002-02       Impact factor: 15.707

Review 3.  The T-cell response in patients with cancer.

Authors:  Chiara Castelli; Markus J Maeurer
Journal:  Adv Cancer Res       Date:  2002       Impact factor: 6.242

4.  Analysis of T cell receptor V(beta) gene expression and clonality in bronchoalveolar fluid lymphocytes from a patient with chronic eosinophilic pneumonitis.

Authors:  N Shimizudani; H Murata; S Kojo; Y Adachi; H Keino; F Tsuchida; M Sumida; M Kawamata; T Sumida; T Matsuoka
Journal:  Lung       Date:  2001       Impact factor: 2.584

5.  Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer.

Authors:  I Saeterdal; J Bjørheim; K Lislerud; M K Gjertsen; I K Bukholm; O C Olsen; J M Nesland; J A Eriksen; M Møller; A Lindblom; G Gaudernack
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

6.  Role of stromal collagen in immunomodulation and prognosis of advanced gastric carcinoma.

Authors:  Satoshi Ohno; Mitsuo Tachibana; Toshiyuki Fujii; Shuhei Ueda; Hirofumi Kubota; Naofumi Nagasue
Journal:  Int J Cancer       Date:  2002-02-20       Impact factor: 7.396

Review 7.  The development of immunotherapies for non-small cell lung cancer.

Authors:  Michael L Salgaller
Journal:  Expert Opin Biol Ther       Date:  2002-03       Impact factor: 4.388

8.  Clinical significance of poor CD3 response in head and neck cancer.

Authors:  Terry Y Shibuya; Nghia Nugyen; Christine E McLaren; Kuo-Tung Li; Wei-Zen Wei; Sanghun Kim; George H Yoo; Amy Rogowski; John Ensley; Wael Sakr
Journal:  Clin Cancer Res       Date:  2002-03       Impact factor: 12.531

9.  The role of lymphocytes and macrophages in human breast tumorigenesis: an immunohistochemical and morphometric study.

Authors:  Herzl Ben-Hur; Ophir Cohen; David Schneider; Pavel Gurevich; Reuvit Halperin; Uri Bala; Marta Mozes; Itshak Zusman
Journal:  Anticancer Res       Date:  2002 Mar-Apr       Impact factor: 2.480

10.  Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer.

Authors:  G Esendagli; K Bruderek; T Goldmann; A Busche; D Branscheid; E Vollmer; S Brandau
Journal:  Lung Cancer       Date:  2007-09-07       Impact factor: 5.705

View more
  4 in total

Review 1.  Cancer stem cells and immunoresistance: clinical implications and solutions.

Authors:  Jordi Codony-Servat; Rafael Rosell
Journal:  Transl Lung Cancer Res       Date:  2015-12

2.  Clinical significance of the induction of macrophage differentiation by the costimulatory molecule B7-H3 in human non-small cell lung cancer.

Authors:  Jing Sun; Yong Mao; Yang-Qin Zhang; Yun-DI Guo; Chuan-Yong Mu; Feng-Qing Fu; Xue-Guang Zhang
Journal:  Oncol Lett       Date:  2013-09-13       Impact factor: 2.967

Review 3.  Mechanisms of immune evasion and current status of checkpoint inhibitors in non-small cell lung cancer.

Authors:  Angel Qin; David G Coffey; Edus H Warren; Nithya Ramnath
Journal:  Cancer Med       Date:  2016-07-15       Impact factor: 4.452

Review 4.  Trends and advances in tumor immunology and lung cancer immunotherapy.

Authors:  Mohanad Aldarouish; Cailian Wang
Journal:  J Exp Clin Cancer Res       Date:  2016-09-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.